Barriers to optimizing inflammatory bowel disease care in the United States

被引：7
|
作者：
Spencer, Elizabeth A. [2 ]
Abbasi, Sadeea [3 ]
Kayal, Maia [1 ]
机构：
[1] Icahn Sch Med Mt Sinai, Henry D Janowitz Div Gastroenterol, One Gustave L Levy Pl Box 1069, New York, NY 10029 USA
[2] Icahn Sch Med Mt Sinai, Div Pediat Gastroenterol, New York, NY USA
[3] Cedars Sinai Santa Monica Gastroenterol, Div Gastroenterol, Santa Monica, CA USA
来源：
THERAPEUTIC ADVANCES IN GASTROENTEROLOGY | 2023年 / 16卷
基金：
美国国家卫生研究院;
关键词：
barriers; inflammatory bowel disease; insurance; HEALTH-CARE; MANAGEMENT; GUIDELINE; THERAPY;
D O I：
10.1177/17562848231169652
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Significant progress in the management and modification of inflammatory bowel disease (IBD) has been made; however, significant barriers to the optimization of IBD care in the United States still exist. The majority of these barriers are constructed by insurance carriers and the integration of market pressures into healthcare decision-making. In this review, we highlight the barriers to IBD care optimization within the context of the US insurance system and review current and proposed solutions.
引用
收藏
页数：14
相关论文
共 50 条
  • [21] The Prevalence of Inflammatory Bowel Disease in the United States Military Healthcare Population
    Armbruster, Steven
    Betteridge, John
    Maydonovitch, Corinne
    Veerappan, Ganesh
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2011, 106 : S445 - S445
  • [22] Hospitalization for Inflammatory Bowel Disease in the United States Between 1970 and 2004
    Sonnenberg, Amnon
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2009, 43 (04) : 297 - 300
  • [23] CURRENT STATUS OF HOME INFUSIONS FOR INFLAMMATORY BOWEL DISEASE IN THE UNITED STATES
    Kochar, Bharati
    Jiang, Yue
    Martin, Christopher F.
    Barnes, Edward L.
    Long, Millie D.
    GASTROENTEROLOGY, 2018, 154 (01) : S72 - S73
  • [24] Geographic distributions of microscopic colitis and inflammatory bowel disease in the United States
    Sonnenberg, Amnon
    Genta, Robert M.
    INFLAMMATORY BOWEL DISEASES, 2012, 18 (12) : 2288 - 2293
  • [25] CURRENT STATUS OF HOME INFUSIONS FOR INFLAMMATORY BOWEL DISEASE IN THE UNITED STATES
    Kochar, Bharati
    Jiang, Yue
    Martin, Christopher F.
    Barnes, Edward L.
    Long, Millie D.
    INFLAMMATORY BOWEL DISEASES, 2018, 24 : S50 - S50
  • [26] Trends of Hospitalization for Pediatric Patients with Inflammatory Bowel Disease in the United States
    Stokes, Audrey
    Hollenbeak, Christopher
    Falaiye, Tolulope
    INFLAMMATORY BOWEL DISEASES, 2016, 22 : S72 - S72
  • [27] ASSOCIATION OF INFLAMMATORY BOWEL DISEASE (IBD) AND BARRIERS TO MEDICAL CARE: RESULTS FROM A NATIONAL SAMPLE REPRESENTATIVE OF OVER THREE MILLION ADULTS WITH IBD IN THE UNITED STATES
    Wong, Carrie R.
    Limketkai, Berkeley N.
    Sauk, Jenny
    GASTROENTEROLOGY, 2020, 158 (06) : S98 - S98
  • [28] UNDERSTANDING BARRIERS TO CARE AND UTILIZATION AMONGST DIVERSE INDIVIDUALS WITH INFLAMMATORY BOWEL DISEASE
    Buadu, Maame Araba
    Khalili, Hamed
    Narain-Blackwell, Melodie C.
    Anyane-Yeboa, Adjoa
    Warner, Erica T.
    GASTROENTEROLOGY, 2024, 166 (05) : S639 - S639
  • [29] PATIENT, PARENT, AND PROVIDER PERCEPTIONS OF BARRIERS TO PEDIATRIC INFLAMMATORY BOWEL DISEASE CARE
    Dotson, Jennifer L.
    Bricker, Josh B.
    Crandall, Wallace V.
    Chisolm, Deena J.
    Mackner, Laura M.
    INFLAMMATORY BOWEL DISEASES, 2018, 24 : S56 - S56
  • [30] Optimizing biologic therapy in inflammatory bowel disease: a Delphi consensus in the United Arab Emirates
    Annese, Vito
    Nathwani, Rahul
    Alkhatry, Maryam
    Al-Rifai, Ahmad
    Al Awadhi, Sameer
    Georgopoulos, Filippos
    Jazzar, Ahmad N.
    Khassouan, Ahmed M.
    Koutoubi, Zaher
    Taha, Mazen S.
    Limdi, Jimmy K.
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2021, 14
12345